Neurofibromin (Nf1) is required for skeletal muscle development
about
RASopathies: unraveling mechanisms with animal modelsMultiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.NF1 is a critical regulator of muscle development and metabolismImmune response and mitochondrial metabolism are commonly deregulated in DMD and aging skeletal muscle.Peripheral muscle weakness in RASopathies.Muscle weakness in children with neurofibromatosis type 1.Skeletal muscle and motor deficits in Neurofibromatosis Type 1.Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patientValosin-containing protein and neurofibromin interact to regulate dendritic spine densityPrmt5 is a regulator of muscle stem cell expansion in adult mice.Developmental effects of tobacco smoke exposure during human embryonic stem cell differentiation are mediated through the transforming growth factor-β superfamily member, Nodal.Multifocal Head and Neck Neurofibromas with Osseous Abnormalities and Muscular Hypoplasia in a Child with Neurofibromatosis: Type I.Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.Myocardial infarction in a 17-year-old patient due to neurofibromatosis-associated coronary aneurysm.Systematic Identification of Genes Regulating Muscle Stem Cell Self-Renewal and Differentiation.Update from the 2013 International Neurofibromatosis Conference.Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge.
P2860
Q26800379-CF398100-DBAF-4572-89F4-334FBEBF0147Q30444110-50A104AA-27D3-48D3-BF8C-A67ADBE73466Q30574056-AEC34FC5-0C9E-4FEE-9AFE-9F4A81E2CAD3Q34077720-020F6CFB-1279-425A-A3F7-AD9DAE83847AQ34295018-5D5C6A71-E83E-44BB-8EDE-8691ED337152Q34473673-5682DFBB-3463-4D5A-AC02-56374F29D109Q34478793-1311F456-E95E-49F5-9418-40EFB519F4D4Q35182111-23E10345-EEB9-4AFE-AE3E-24678F205091Q35578562-1B73BFA3-B08F-4AD2-B135-96E2A1B2B600Q35692683-A8A731AD-8C69-4D48-A038-E2F4F960567EQ35856927-7143D61A-7449-4E2A-B21C-0BD0254BFACEQ37038284-AB207422-CEDD-4493-AAE4-C021B764C354Q39957055-7E40DFAE-4F46-41BD-AD72-8463C32D7DAAQ50926872-847D3390-2D20-4589-AD7F-AB3510F0E4DEQ52899771-481AB173-87E9-41D1-B2DC-D23D13A5DA1FQ53083642-074C2BDC-19F7-4677-8516-A4B132B8BD3BQ53120030-A7B981E5-5772-466C-818C-510CCE540EA2
P2860
Neurofibromin (Nf1) is required for skeletal muscle development
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Neurofibromin (Nf1) is required for skeletal muscle development
@ast
Neurofibromin (Nf1) is required for skeletal muscle development
@en
type
label
Neurofibromin (Nf1) is required for skeletal muscle development
@ast
Neurofibromin (Nf1) is required for skeletal muscle development
@en
prefLabel
Neurofibromin (Nf1) is required for skeletal muscle development
@ast
Neurofibromin (Nf1) is required for skeletal muscle development
@en
P2093
P2860
P50
P356
P1476
Neurofibromin (Nf1) is required for skeletal muscle development
@en
P2093
Carola Dietrich
Christian Rödelsperger
David A Stevenson
Mateusz Kolanczyk
Monika Osswald
Stefan Mundlos
P2860
P304
P356
10.1093/HMG/DDR149
P50
P577
2011-04-09T00:00:00Z